Bio-Techne Corp Stock News

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either GSK (GSK) or Techne (TECH). But which of these two stocks is more attractive to value investo

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with GSK (GSK) and Techne (TECH). But which of these two stocks is more attractive to value investors?

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either GSK (GSK) or Techne (TECH). But which of these two stocks presents investors with the better

Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Puma Biotech (PBYI) and Techne (TECH). But which of these two companies is the best option for those

Bio-Techne Corporation has been a long term value creator, combining organic growth with sound M&A deals. This has resulted in long-term value creation, as Bio-Techne Corporation shares have looked pr

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Puma Biotech (PBYI) or Techne (TECH). But which of these two companies is the best option for

MINNEAPOLIS , May 12, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Jim Hippel, Executive Vice President and Chief Financial Officer, will present at the 2023 RBC Cap

Bio-Techne Corporation (NASDAQ:TECH ) Q3 2023 Earnings Conference Call May 3, 2023 9:00 AM ET Company Participants David Clair – Vice President-Investor Relations Chuck Kummeth – Chief Executive O

Techne (TECH) came out with quarterly earnings of $0.53 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.54 per share a year ago.

Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both GSK (GSK) and Techne (TECH). But which of these two companies is the best option for those looking f

Fundamentally, the driving catalyst for biotech stocks to buy centers on the possibility of supporting paradigm-shifting medical breakthroughs. For example, a report published by the JAMA Network indi

MINNEAPOLIS , March 10, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Jim Hippel, Executive Vice President and Chief Financial Officer, will present at the Barclays G

MINNEAPOLIS , Feb. 28, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Cowen 43rd Annual Heal

Bio-Techne Corporation (NASDAQ:TECH ) Q2 2023 Earnings Conference Call February 2, 2023 9:00 AM ET Company Participants David Clair - Vice President of Investor Relations Chuck Kummeth - Chief Executi

Techne (TECH) delivered earnings and revenue surprises of -4.08% and 6.34%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?